Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy

AIDS

Volumn 17, Issue 1, 2003, Pages 81-87

  Gérard, Laurence ^a   Galicier, Lionel ^a   Boulanger, Emmanuelle ^a   Quint, Laurent ^a   Lebrette, Marie Giselle ^b   Mortier, Emmanuel ^c   Meignin, Véronique ^a   Oksenhendler, Eric ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c HÔPITAL LOUIS MOURIER   (France)

Author keywords

CD4; Haematology; Highly active antiretroviral therapy; Hodgkin's lymphoma; Survival; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CHEMOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EVALUATION; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURVIVAL; VIRUS LOAD;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; VIRAL LOAD;

EID: 0037415024     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200301030-00011     Document Type: Article

References (37)

1. Goedert JJ. The epidemiology of acquired imunodeficiency syndrome malignancies. Semin Oncol 2000; 27:390-401.
2. Franceschi S, Dal Maso L, Arniani S, Crosignani P, Vercelli M, Simonato L, et al. Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Br J Cancer 1998; 78:966-970.
3. Robert NJ, Schneiderman H. Hodgkin's disease and the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101:142-143.
4. Franchesi S, Dal Maso L, La Vecchia C. Advances in the epidemiolgy of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms. Int J Cancer 1999; 83:481-485.
5. Reynolds P, Saunders LD, Layefsky ME, Lemp GF. The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco, 1980-1987. Am J Epidemiol 1993; 137:19-30.
6. Clarke CA, Glaser SL. Epidemiologic trends in HIV-associated lymphomas. Curt Opin Oncol 2001; 13:354-359.
7. Serraino D, Boschini A, Carrieri P, Pradier C, Darrucci M, Dal Maso L,et al. Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS 2000; 14:553-559.
8. Grulich AE. Update: cancer risk in persons with HIV/AIDS in the era of combination antiretroviral therapy. AIDS Read 2000; 10:341-346.
9. Frisch M, Biggar RJ, Engels EA, Goeert JJ, AIDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001; 285:1736-1745.
10. Vaccher E, Spina M, Tirelli U. Clinical aspects and management of Hodgkin's disease and other tumours in HIV-infected individuals. Eur J Cancer 2001; 37:1306-1315.
11. Tirelli U, Errante D, Dolcetti R, Gloghini A, Serraino D, Vaccher E, et al. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 1995; 13:1758-1767.
12. Ree HJ, Strauchen JA, Khan AA, Gold JE, Crowley JP, Kahn H, et al. Human immunodeflciency virus-associated Hodkin's disease. Clinicopathologic studies of 24 cases and preponderance of mixed cellularity type characterized by the occurrence of fibrohistiocytoid stromal cells. Cancer 1991; 67:1614-1621.
13. Rubio R. Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cancer 1994; 73:2400-2407.
14. Levy R, Colonna P, Tourani JM, Gastaut JA, Brice P, Raphaël M, et al. Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors. Leuk Lymphoma 1995; 16:451-456.
15. Spina M, Vaccher E, Nasti G, Tirelli U. Human immunodeficiency virus-associated Hodgkin's disease. Semin Oncol 2000; 27:480-488.
16. Tirelli U, Spina M, Gaidano G, Vaccher E, Franceschi S, Carbone A, et al. Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy. AIDS 2000; 14:1675-1688.
17. Powles T, Bower M. HIV-associated Hodgkin's disease. Int J STD AIDS 2000; 11:492-494.
18. Carbone A, Docetti R, Gloghini A, Maestro R, Vaccher E, diLuca D, et al. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study. Hum Pathol 1996; 27:133-146
19. Herndier BG, Sanchez HC, Chang KL, Chen YY, Weiss LM. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin's disease. Am J Pathol 1993; 142:1073-1079.
20. Siebert JD, Ambinder RF, Napoli VM, Quintanilla-Martinez L, Banks PM, Gulley ML. Human immunodeficiency virus-associated Hodgkin's disease contains latent, not replicative, Epstein-Barr virus. Hum Pathol 1996; 26:1191-1195.
21. Urba WJ, Longo DL. Hodgkin's disease. N Engl J Med 1992; 326:678-687.
22. Aisenberg AC. Problems in Hodgkin's disease management. Blood 1999; 93:761-779.
23. Errante D, Zagonel V, Vaccher E, Serraino D, Bernardi D, Sorio R, et al. Hodgkin's disease in patients with HIV infection and in the general population: Comparison of clinicopathological features and survival. Ann Oncol 1994; 5(Suppl 2):S37-S40.
24. Errante D, Gabarre J, Ridolfo AL, Rosi G, Nosari AM, Gisselbrecht C, et al. Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherpy in combination with antiretroviral therapy and primary use of G-CSF. Ann Oncol 1999; 10:189-195.
25. Palella FJJ, Delaney KM, Moorman AC, Loveless MU, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853-860.
26. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000; 92:1823-1830.
27. Antinori A, Gingolani A, Alba L, Ammassari A, Serraino D, Ciancio BC, et al. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS 2001; 15:1483-1491.
28. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31:1860-1861.
29. Jaffe E, Harris NL, Diebold J, Diebold J, Muller-Hermelink HK. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. Am J Clin Pathol 1999; 111 (Suppl. 1):S8-S12.
30. Longo DL, Young RC, Wesley M, Hubbard SM, Duffey PL, Jaffe ES, et al. Twenty years of MOPP therapy for Hodgkin's disease. J Clin Oncol 1986; 4:1295-1306.
31. Santoro A, Bonfante V, Bonadonna G. Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease. Ann Intern Med 1982; 96:139-143.
32. Klimo P, Connors JM. An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program. Semin Hematol 1988; 25 (Suppl. 2):34-40.
33. Jones SE, Grozea PN, Metz EN, Haut A, Stephens RL, Morrison FS, et al. Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma. A SWOG study. Cancer 1979; 43:417-425.
34. Lyter DW, Bryant J, Thackeray R, Rinaldo CR, Kingsley LA. Incidence of human immunodeficiency virus-related and non-related malignancies in a large cohort of homosexual men. J Clin Oncol 1995; 13:2540-2546.
35. Peter JB. High, low, and very low viral loads of HIV in the United States. J Acquir Immune Defic Syndr 2000; 24:83-84.
36. Gérard L, Galicier L, Maillard A, Boulanger E, Quint L, Matherson S, et al. Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival. J Acquir Immune Defic Syndr 2002 30:478-484.
37. Errante D, Gabarre J, Fasan M, Fasan M, Schientarelli C, Nigra E, et al. Feasibility of the integration of Stanford V chemotherapy regimen with highly active antiretroviral therapy (HAART) and G-CSF in patients with Hodgkin's disease and HIV infection. AIDS 2000; 14:1457-1458.